Skip to main content
. 2014 Oct 15;7(10):3258–3269.

Figure 3.

Figure 3

Meta-analysis comparing IL-17 expression and progression-free survival (PFS) in cancer patients. A. The individual and pooled HR with 95% CIs was shown by forest blot. Heterogeneity was calculated by measuring the inconsistency (I2) and by the Cochrane Q test (Chi-squared test; Chi2). B. Funnel blot was used to reflect a potential publication bias.